Document Detail


Warfarin therapy does not increase risk of symptomatic intracerebral hemorrhage in eligible patients after intravenous thrombolysis.
MedLine Citation:
PMID:  21220688     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
Authors:
Dimitriy Levin; Don B Smith; Ethan Cumbler; Jeffrey Carter; Jeffrey J Glasheen; William Jones
Related Documents :
1692088 - Carbon monoxide diffusing capacity is a poor predictor of clinically significant bleomy...
21464348 - The systemic capillary leak syndrome: a case series of 28 patients from a european regi...
24516308 - Report of patients with chronic myeloid leukemia, from hematology clinic, ahmedabad, gu...
21196868 - Prevalence of impacted premolars in a turkish population and considerations for surgica...
18033838 - Characterization of skin microbiota in patients with atopic dermatitis and in normal su...
20158288 - 'first, do no harm': factors that influence pharmacists making decisions about over-the...
Publication Detail:
Type:  Comment; Letter; Research Support, U.S. Gov't, Non-P.H.S.    
Journal Detail:
Title:  Archives of neurology     Volume:  68     ISSN:  1538-3687     ISO Abbreviation:  Arch. Neurol.     Publication Date:  2011 Jan 
Date Detail:
Created Date:  2011-01-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0372436     Medline TA:  Arch Neurol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  135; author reply 135-6     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Comments/Corrections
Comment On:
Arch Neurol. 2010 May;67(5):559-63   [PMID:  20212195 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Stridor as a neonatal presentation of skeletal muscle sodium channelopathy.
Next Document:  Critical role of IRF-8 in negative regulation of TLR3 expression by Src homology 2 domain-containing...